MT
Healthcare & Life Sciences

MitoImmune Therapeutics

MitoImmune Therapeutics is a Healthcare & Life Sciences startup based in Seoul, South Korea, most recent round Series B.

Activeseries-b
series-b
Stage

About MitoImmune Therapeutics

Based in Seoul, South Korea, MitoImmune Therapeutics is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences.

MitoImmune Therapeutics develops therapeutics targeting mitochondrial dysfunction and immune system regulation for treating autoimmune diseases and inflammatory conditions.

Explore MitoImmune Therapeutics's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in South Korea